Eko Prasetyo, Andi Asadul Islam, Mochammad Hatta, Djoko Widodo and Ilhamjaya Pattelongi. Downregulation of MMP-9 Level and GCS Score Improvement in Severe Traumatic Brain Injury Due to the Mild Hypothermia Therapy.
. 2017; 5(2):18-22. doi: 10.12691/AJMBR-5-2-2
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | C.Werner, and Engelhard, “Pathophysiology of traumatic brain injury,” Brit J Anaesth, vol., 99, no.1, pp.4-9, 2007. |
|
[2] | M.C.Falo, H, Fillmore, and T.M.Reeves, “Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury”, J Neurosci Res, vol.84, pp.768-781, 2006. |
|
[3] | T.Higashida, C.W.Kreipke, J.A.Rafols JA, et al., “The role of hypoxia – inducible factor-1 alpha, aquaporin-4 and matrix metalloproteinase-9 in blood brain barrier disruption and brain edema after traumatic brain injury”, J Neurosurg, vol.114, pp. 92-101, 2011. |
|
[4] | M.Kolar, J.Pachl, and H.Tomasova, “Dynamics of matrix-metalloproteinase 9 after brain trauma-results of a pilot study”, Act Neurochir Suppl, vol.102, pp. 373-376, 2008. |
|
[5] | D.J.Roberts, C.N.Jenne, C.Léger C, et al., “Association between the cerebral inflammatory and matrix metalloproteinase responses after severe traumatic brain injury,” J Neurotrauma, vol.30, pp.1727-1736, 2013. |
|
[6] | T.L.Barr, L.L.Latour, K.Y.Lee KY et al., “Blood-brain barrier disruption in humans is independently associated with increased matrix-metalloproteinase-9”, Stroke, vol.41, pp.123-128, 2010. |
|
[7] | C.M.Atkins, A.A. Oliva Jr., O.F.Alonso OF et al., “Hypothermia treatments potentiates ERK1/2 activation after traumatic brain injury”, Eur J Neurosci, vol.26, pp.810-819, 2007. |
|
[8] | A.R.Jayakumar, X.Y.Tong, R.Ruiz-Cordero et al., “Activation of NF-κB mediates astrocyte swelling and brain edema in traumatic brain injury,” J Neurotrauma,vol.31, pp.1-9, 2014. |
|
[9] | T.Mori, X.Wang, T.Aoki, and E.H.Lo, “Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK Mitogen Activated Protein Kinase in traumatic brain injury”, J Neurotrauma, vol 19, pp.1411-1419, 2002. |
|
[10] | K.R.L.Schmitt , A. Diestel, S.Lehnardt S , et al. “Hypothermia suppresses inflammation via ERK signaling pathway in stimulated microglial cells,” J Neuroimmunol, vol.189, pp.7-16, 2007 |
|
[11] | Westermarck J, Kahari W. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J, 13: 781-792, 1999. |
|
[12] | Gal R, Cundrle I, Zimova I, Smrcka M. Mild hypothermia therapy for patients with severe brain injury. Clin Neurol Neurosurg, 104: 318-321, 2002. |
|
[13] | Jiang JY. Clinical study of mild hypothermia treatment for severe traumatic brain injury. J Neurotrauma 2009; 26: 399-406. |
|
[14] | Jiang JY, Yu MK, Zhu C. Effect of long-term mild hypothermia therapy in patients with severe traumatic brain injury: 1-year follow-up review of 87 cases. J Neurosurg 2000; 93: 546-549. |
|
[15] | Lei J, Gao G, Mao Q, Feng J, Wang L. Rationale, methodology, and implementation of a nationwide multicenter randomized controlled trial of long-term mild hypothermia for severe traumatic brain injury (the LTH-1 trial). Contemp Clin Trials 2015; 40: 9-14. |
|
[16] | Tang C, Bao Y, Qi M, Zhou L, Liu F, Mao J et al. Mild induced hypothermia for patients with a severe traumatic brain injury after decompressive craniectomy. J Crit Care 2017; 39: 267-270. |
|
[17] | Dietrich WD. Therapeutic hypothermia in experimental models of traumatic brain injury. In: N. Hayashi, editor. Brain hypothermia. Tokyo: Springer-Verlag, 2000, 39-46. |
|
[18] | Dietrich WD, Bramlett HM. The evidence for hypothermia as a neuroprotectant in traumatic brain injury. Neurotherapeutics 2010; 7(1): 43-50. |
|
[19] | Polderman KH. Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1, indications and evidence. Intensive Care Med 2004; 30: 556-575. |
|
[20] | Sahuquillo J, Vilalta A. Cooling the injured brain: how does moderate hypothermia influence the pathophysiology of traumatic brain injury. Curr Pharm Des 2007; 13: 2310-2322. |
|
[21] | Jurkovich GJ, Pitt RM, Curreri PW, Granger DN. Hypothermia prevents increased capillary permeability following ischemia-reperfusion injury. J Surg Res 1998; 44: 514-521. |
|
[22] | Lotocki G, de Rivero Vaccari JP, Perez ER, Sanchez-Molano J, Furones-Alonso O, Bramlett HM, et al. Alterations in blood-brain barrier permeability to large and small molecule and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J Neurotrauma 2009; 26: 1123-1134. |
|
[23] | Suehiro E, Fujisawa H, Akimura T. Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. J Neurotrauma 2004; 21: 1706-1711. |
|
[24] | Truettner JS, Alonso OF, Dalton DW. Influence therapeutic hypothermia on matrix metalloproteinases activity after traumatic brain injury in rats. J Cereb Blood Flow Metab 2005; 25: 1505-1516. |
|
[25] | Udekwu P, Schiro SK, Vaslef S, Baker C, Oller D. Glasgow Coma Scale Score, Mortality, and Functional Outcome in Head-Injured Patients. J Trauma 2004; 56: 1084-1089. |
|
[26] | Balestreri M, Czosnyka M, Chatfield DA, Steiner LA, Schmidt EA, Smielewski P, et al. Predictive value of Glasgow coma scale after brain trauma: change in trend over the past ten years. J Neurol Neurosurg Psychiatry 2004; 75: 161-162. |
|
[27] | Jia F, Pan YH, Mao Q, Liang Y, Jiang J. Matrix metalloproteinase-9 expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. J Neurotrauma 2010; 27: 1059-1068. |
|
[28] | Andresen M, Gazmuri JT, Marín A, Regueira T, Rovegno M. Therapeutic hypothermia for acute brain injuries. Scan J Trauma Res Emerg Med 2015; 23(42): 1-7. |
|
[29] | Polderman KH. Mechanism of action, physiological effects, and complication of hypothermia. Crit Care Med 2009; 37: S186-202. |
|
[30] | Fox JL, Vu EN, Doyle-Waters M, Brubacher JR, Abu-Laban R, Hu Z. Prophylactic hypothermia for traumatic brain injury: a quantitative systematic review. CJEM 2010; 12: 355-364. |
|
[31] | Peterson K, Carson S, Carney N. Hypothermia treatment for traumatic brain injury: a systematic review and meta-analysis. J Neurotrauma 2008; 25: 62-71. |
|
[32] | Yaglom J, O’Callaghan-Sunol, C Gabai V. Inactivation of dual-specificity phosphatases are involved in the regulation of extracellular signal-regulated kinases by heat shock and hsp 72. Mol Cell Biol 2003; 23: 3813-3824. |
|
[33] | Han HS, Karabiyikoglu M, Kelly S, Sobel RA, Yenari MA. Mild hypothermia inhibits nuclear factor-kB translocation in experimental stroke. J Cereb Blood Flow Metab 2003; 23: 589-598. |
|
[34] | Han HS, Park J, Kim J, Suk K, Molecular and cellular pathways as a target of therapeutic hypothermia: pharmacological aspect. Curr Neuropharmacol 2012; 10: 80-87. |
|
[35] | Fini ME, Cook JR, Mohan R, Brinkerhoff CE. Regulation of matrix metalloproteinase gene expression. In: Parks WC, Mecham RP, editors. Matrix Metalloproteinases. New York, NY: Academic Press, 1998, 299-356. |
|
[36] | Vu TH, Werb Z. Gelatinase B, structure, regulation and function. In: Parks WC, Mecham RP, editors. Matrix Metalloproteinases. New York, NY: Academic Press, 1998, 115-117. |
|
[37] | Lee JE, Yoon YJ, Moseley ME, Yenari MA. Reduction in levels of matrix metalloproteinases and increased expression of tissue inhibitor of metalloproteinase-2 in response to mild hypothermia therapy in experimental stroke. J Neurosurg 2005; 103: 289-297. |
|